instruction:
Given a passage classify if the passage has a definite objective/aim/goal or not. Output '1' if the passage has a defininte objective/aim/goal and output '0' if the passage does not have a definite objective/aim/goal.
question:
Three-dimensional (3D) surface matching is a novel method to administer deep inspiration breath-hold (DIBH) radiation therapy for left-sided breast cancer to reduce cardiac exposure. We analyzed port (x-ray) films to assess patient setup accuracy and treatment times to assess the practical workflow of this system.', 'The data from 50 left-sided breast cancer patients treated with DIBH were studied. AlignRT (London, UK) was used. The distance between the field edge and the anterior pericardial shadow as seen on the routine port films (dPORT), and the corresponding distance seen on the digitally reconstructed radiographs (DRR) from the planning (dDRR) were compared as a quantitative measure of setup accuracy. Variations of dPORT - dDRR over the treatment course were assessed. In a subset of 21 patients treated with tangential beams alone, the daily treatment durations were analyzed to assess the practical workflow of this system.', 'Considering all 50 patients, the mean absolute systematic uncertainty between dPORT and dDRR was 0.20 cm (range, 0 to 1.22 cm), the mean systematic uncertainty was -0.07 cm (range, -1.22 to 0.67 cm), and their mean random uncertainty was 0.19 cm (range, 0 to 0.84 cm). There was no significant change in dPORT - dDRR during the course of treatment. The mean patient treatment duration for the 21 patients studied was 11 minutes 48 seconds. On intrapatient assessments, 15/21 had nonsignificant trends toward reduced treatment durations during their course of therapy. On interpatient comparisons, the mean treatment times declined as we gained more experience with this technique.
answer:
1


question:
Parasympathetic dysfunction is an independent risk factor for mortality in heart failure for which there is no specific pharmacologic treatment. This article aims to determine the effect of pyridostigmine, an anticholinesterase agent, on the integrated physiologic responses to dynamic exercise in heart failure.', 'Patients with chronic heart failure (n = 23; 9 female; age = 48 +/- 12 years) were submitted to 3 maximal cardiopulmonary exercise tests on treadmill in different days. The first test was used for adaptation and to determine exercise tolerance. The other tests were performed after oral administration of pyridostigmine (45 mg, 3 times/day, for 24 hours) or placebo, in random order. All patients were taking their usual medication. Pyridostigmine reduced cholinesterase activity by 30%, inhibited the chronotropic response throughout exercise, up to 60% of maximal effort (pyridostigmine = 108 +/- 3 beats/min vs. placebo = 113 +/- 3 beats/min; P = .040), and improved heart rate reserve (pyridostigmine = 73 +/- 5 beats/min vs. placebo = 69 +/- 5 beats/min; P = 0.035) and heart rate recovery in the first minute after exercise (pyridostigmine = 25 +/- 2 beats/min vs. placebo = 22 +/- 2 beats/min; P = .005), whereas peak heart rate was similar to placebo. Oxygen pulse, an indirect indicator of stroke volume, was higher under pyridostigmine during submaximal exercise.
answer:
0


question:
To determine the effects of co-ingesting caffeine (CAF) and carbohydrate (CHO) on high-intensity intermittent sprints (HIS) performance and physiological responses.', 'Twelve active males underwent 4 interventions at least 7\xa0days apart in a randomized, double-blind, placebo-controlled, balanced trial. A meal contained 65\xa0% CHO was provided 2\xa0h before the HIS test. Participants ingested the placebo (PLA) or CAF (6\xa0mg\xa0kg(-1) BW) 1\xa0h before taking an HIS test, and ingested a PLA or CHO solution (0.8\xa0g\xa0kg(-1)\xa0BW) before undergoing the testing protocol. The HIS protocol comprised ten sets of 5\xa0×\xa04-s sprints on a cycle ergometer with a 2-min recovery between each set.', 'There was no significant difference between peak power output and mean power output between trials (p\xa0>\xa00.05). Compared with PLA, CAF\xa0+\xa0CHO resulted in a 5.2\xa0% reduction in total work, corresponding to a 24.7-25.7\xa0% increase in fatigue at the end stage of the HIS. The administration of CAF\xa0+\xa0CHO supplementation also resulted in an 11.1\xa0% increase in blood lactate, and elevated blood glucose concentrations throughout HIS testing compared with PLA (p\xa0<\xa00.05). Cortisol concentrations also increased with CAF\xa0+\xa0CHO intake compared with PLA; however, there was no significant effect of CAF\xa0+\xa0CHO supplementation on testosterone concentrations.
answer:

1